Management of the overweight patient with Type 2 diabetes.
Peter
P
P
Birmingham Heartlands Hospital, Birmingham, UK.
Kumar
S
S
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy / Q000209:etiology*; D000077403:Orlistat; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D019440:Anti-Obesity Agents; D003503:Cyclobutanes; D007004:Hypoglycemic Agents; D007783:Lactones; D008687:Metformin; D000077403:Orlistat; D017367:Selective Serotonin Reuptake Inhibitors; D013453:Sulfonylurea Compounds; C058254:sibutramine